Back to Browse Journals » International Journal of Women's Health » Volume 2

Optimal management of nausea and vomiting of pregnancy

Authors Neda Ebrahimi, Caroline Maltepe, Adrienne Einarson

Published Date August 2010 Volume 2010:2 Pages 241—248

DOI http://dx.doi.org/10.2147/IJWH.S6794

Published 4 August 2010

Neda Ebrahimi1,2, Caroline Maltepe2, Adrienne Einarson2

1Pharmaceutical Sciences, University of Toronto, Toronto, Ontario, Canada; 2Motherisk Program, The Hospital for Sick Children, Toronto, Ontario, Canada

Abstract: Nausea and vomiting of pregnancy (NVP) is a common medical condition in pregnancy with significant physical and psychological morbidity. Up to 90% of women will suffer from NVP symptoms in the first trimester of pregnancy with up to 2% developing hyperemesis gravidarum which is NVP at its worst, leading to hospitalization and even death in extreme cases. Optimal management of NVP begins with nonpharmacological approaches, use of ginger, acupressure, vitamin B6, and dietary adjustments. The positive impact of these noninvasive, inexpensive and safe methods has been demonstrated. Pharmacological treatments are available with varying effectiveness; however, the only drug marketed specifically for the treatment of NVP in pregnancy is Diclectin® (vitamin B6 and doxylamine). In addition, the Motherisk algorithm provides a guideline for use of safe and effective drugs for the treatment of NVP. Optimal medical management of symptoms will ensure the mental and physical wellbeing of expecting mothers and their developing babies during this often stressful and difficult time period. Dismissing NVP as an inconsequential part of pregnancy can have serious ramifications for both mother and baby.

Keywords: pharmacological/nonpharmacological treatments, NVP

A Letter to the Editor has been received and published for this article.

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Does wine prevent dementia?

Roger M Pinder

International Journal of Wine Research 2009, 1:41-52

Published Date: 4 February 2009

Wine consumers’ environmental knowledge and attitudes: Influence on willingness to purchase

Nelson Barber, Christopher Taylor, Sandy Strick

International Journal of Wine Research 2009, 1:59-72

Published Date: 9 February 2009

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors

Eduardo Pimenta, Suzanne Oparil

Vascular Health and Risk Management 2009, 5:453-463

Published Date: 19 May 2009

Treating dyspareunia caused by vaginal atrophy: a review of treatment options using vaginal estrogen therapy

SA Kingsberg, S Kellogg, M Krychman

International Journal of Women's Health 2009, 1:105-111

Published Date: 20 August 2009

Epigenomics in cancer management

Fabricio F Costa

Cancer Management and Research 2010, 2:255-265

Published Date: 27 October 2010

Moderate alcohol consumption and cognitive risk

Neafsey EJ, Collins MA

Neuropsychiatric Disease and Treatment 2011, 7:465-484

Published Date: 11 August 2011

Letter to editor

Reichmann JP

International Journal of Women's Health 2013, 5:35-36

Published Date: 22 January 2013

Outcomes in hypertensive disorders of pregnancy in the North Indian population

Sachan R, Patel ML, Sachan P, Gaurav A, Singh M, Bansal B

International Journal of Women's Health 2013, 5:101-108

Published Date: 6 March 2013

Limitations of using synthetic blood clots for measuring in vitro clot capture efficiency of inferior vena cava filters

Robinson RA, Herbertson LH, Sarkar Das S, Malinauskas RA, Pritchard WF, Grossman LW

Medical Devices: Evidence and Research 2013, 6:49-57

Published Date: 10 May 2013